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ABSTRACT
INTRODUCTION: The primary aim of the study was to compare the laboratory and radiological parameters 
of COVID-19 positive and negative patients confirmed by Real-Time Reverse Transcription Polymerase Chain 
Reaction (RT-PCR), and Chest Computed Tomography (CCT) of patients admitting with the suspicion of 
COVID-19. The secondary purpose of the study was to find objective parameters to speed up the clinician 
for further examination, treatment or referral decision in COVID-19 suspicion.
MATERIAL AND METHODS: A total of 61 COVID-19 suspected patients were evaluated in the study. Swab 
samples were taken for RT-PCR analysis. CCT was taken for 42 patients who described dyspnea.
According to CCT and RT-PCR results, the patient population was divided into 2 groups as COVID-19 positive 
group (n = 32); and COVID-19 negative group (n = 29). Between two groups; demographic, clinical, labo-
ratory and radiological parameters were compared.
RESULTS: Male gender (p = 0.03), PLR value (p = 0.021) and CO-RADS scores were higher in the COVID-19  
positive group. Oxygen saturation (SaO2) (p = 0.027) and PCT, WBC, Neutrophil count, Lymphocyte  
count values were significantly low in COVID-19 positive group (p = 0.03, p = 0.001, p = 0.017, p = 0.021, 
respectively). PLR showed a positive correlation with fever, CRP, neutrophil count and NLR, which are indi-
cators of inflammation.
CONCLUSIONS: SaO2, WBC, lymphocyte count, neutrophil count and low PCT levels, and PLR elevation 
showed a significant difference in COVID-19 patients in our retrospective cohort study examining the Turkish 
population. We believe that these results will allow clinicians to make quick decisions in patient management 
more simply.
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INTRODUCTION
The disease that was caused by SARS-CoV-2 (COV-
ID-19) first appeared in Wuhan, China in December 
2019, then affected the whole world, and was rec-
ognized as pandemic by the World Health Organi-
zation (WHO) on February 11, 2020 [1]. 
COVID-19 is a very contagious disease and usu-
ally manifests with nonspecific respiratory symp-
toms like fever, cough, and shortness of breath [2]. 
The clinical manifestation of the disease usually oc-
curs as fever (body temperature 37–38°C), cough, 
nasal congestion and fatigue, which usually begin 
in 1 week in symptomatic patients [3], and can then 
progress to pneumonia [4].
Although it was shown that COVID-19 first 
occurred as a respiratory infection, the data that 
emerged later suggested that it should be consid-
ered as a systemic disease involving many systems, 
including cardiovascular, respiratory, gastrointestinal, 
neurological, hematopoietic and the immune system 
itself [5, 6]. Since there are nonspecific symptoms 
and rapid deterioration of the clinical manifestations, 
the importance of accessible laboratory tests has 
increased to enable us to obtain quick results in the 
diagnosis of COVID-19 allowing us to determine its 
prognosis. Hematological and biochemical biomark-
ers provide us both objective perspective during the 
course of the disease and help to classify the disease 
as mild, severe or critical, allowing the diagnosis and 
treatment process to proceed faster [7].
For this reason, there are many studies that 
evaluate the relation of laboratory parameters with 
COVID-19, and these studies are usually associated 
with the clinical progression of COVID-19 [7]. 
The primary purpose of the present study was to 
compare the laboratory and radiological parameters 
of COVID-19 positive and negative patients con-
firmed by Real-Time Reverse Transcription Polymer-
ase Chain Reaction (RT-PCR), and Chest Computed 
Tomography (CCT) of patients admitting with the 
suspicion of COVID-19. The secondary purpose of 
the study was to find objective parameters to speed 
up the clinician for further examination, treatment 
or referral decision in COVID-19 suspicion.
MATERIAL AND METHODS
Before the study was initiated, approval was ob-
tained from the Ethics Board of Ufuk University (No: 
20200521/9). A total of 61 COVID-19 suspected 
patients according to the Turkish Republic Ministry 
of Health COVID-19 Guideline, admitting to the 
university hospital emergency department between 
05.03.2020 and 27.04.2020 were evaluated in the 
study [8]. According to the anamnesis of the pa-
tients; the demographic data, comorbidities, and 
smoking habits were recorded as the admission 
complaints. Detailed physical examinations were 
made after the vital findings of the patients were 
recorded. The Complete Blood Count (CBC), (includ-
ing White Blood Cell (WBC), lymphocyte count, neu-
trophil count, platelet (PLT), Mean Platelet Volume 
(MPV), plateletcrit (PCT), Platelet Distribution Width 
(PDW), which are infection-related parameters in 
suspected patients of COVID-19, lactate dehydro-
genase (LDH) from biochemical markers, C-reactive 
protein (CRP) and ferritin from acute phase reac-
tants, and D-Dimer tests were performed for throm-
bosis. Also, Neutrophil/Lymphocyte Ratio (NLR) and 
Platelet-Lymphocyte Ratio (PLR) were calculated. 
Swab samples were taken for RT-PCR analysis. CCT 
was carried out for 42 patients who described dysp-
nea. The CCTs were classified by a radiologist accord-
ing to CO-RADS 1–6 [9]. As previously defined, CO-
RADS 1–3 groups were included in the Radiological 
COVID19 negative group; and CO-RADS 4–6 were 
included in the COVID-19 positive group. 
According to CCT and RT-PCR results, the patient 
population was divided into 2 groups as COVID-19 
positive patients COVID-19 positive group 
(n = 32); and according to CCT and RT-PCR results, 
COVID-19 negative patients COVID-19 negative 
group (n = 29). 
Exclusion criteria: The patients who were diag-
nosed with other pulmonary infections other than 
COVID-19, those with malignancies, those under 
the age of 18, and pregnant women were not in-
cluded in the study.
The demographic, clinical, laboratory and radio-
logical parameters between COVID-19 positive and 
negative groups were compared.
Statistical Analysis
Statistical analysis was performed with SPSS, 
v.23.0 statistical software (SPSS, Inc., Chicago, IL, 
USA). The categorical variables were described as 
frequencies and percentages. Continuous varia-
bles were presented as mean and standard devia-
tions. Chi-square (χ2) tests were used to evaluate the 
relationship between categorical variables of study 
subgroups. Independent T test and Mann Whitney 
U test for the comparison of two groups were the 
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tests used in continuous variables. Pearson’s corre-
lation coefficients of continuous variables were also 
calculated. P values below 0.05 were considered 
statistically significant.
RESULTS
The mean age of the patients was 46.6 ± 18.6, and 
the male/female ratio was 44.3%/55.7% (27/34). 
A total of 45.9% (28/61) patients did not have co-
morbidities, ut 27.9% (17/61) had multiple comor-
bidities, and among the comorbidities, the mostly 
detected ones were; hypertension: 37.7% (23/61), 
diabetes mellitus: 13.1% (8/61), coronary artery dis-
ease: 11.4% (7/61), asthma: 8.2% (5/61), respective-
ly. A total of 29.3% patients had a smoking habit. 
Multiple admission complaints were determined in 
41% patients (25/61), and the most common com-
plaints were cough, fever and shortness of breath, 
respectively. CCT was performed because of clinical 
suspicion in 68.9% (42/61) patients. According to 
CCT results, in COVID-19 Reporting and Data Sys-
tem (CORADS) classification, the following results 
were obtained: CORADS1: 22 (52.4%), CORADS 
2:5 (11.9%), CORADS 3: 2 (4.8%), CORADS 4: 5 
(11.9%) CORADS 5: 1(2.4%) CORADS6: 7(16.7%). 
A total of 26 patients (42.6%) were reported to 
be RT-PCR positive. Covid-19 was detected to be 
positive in 52.5% (32/61) (CO-RADS 4-5-6 and/or 
RT-PCR+), and negative in 47.5% (29/61) (CO-RADS 
1-2-3 and RT-PCR). 
The following were determined in the evaluation 
of the demographic, clinical, laboratory and radio-
logical parameters of COVID-19 positive and nega-
tive groups. Male gender was more dominant in de-
mographic parameters in COVID-19 positive group 
(p = 0.03); oxygen saturation (SaO2) (p = 0.027) 
from clinical parameters, and PCT, WBC, Neutro-
phil count, Lymphocyte count values were low at 
significant levels (p = 0.03, p = 0.001, p = 0.017, 
p = 0.021, respectively); PLR value was significantly 
higher (p = 0.021), and the CO-RADS scores from 
radiological parameters were higher as expected in 
COVID-19 positive group (p < 0.001) (Tab. 1).
In the correlation analysis: SaO2 showed a neg-
ative correlation with neutrophil count, NLR, WBC, 
CRP, ferritin, D-dimer and LDH. NLR showed a pos-
itive correlation with WBC, CRP and D-Dimer. PCT 
showed a negative correlation with LDH and positive 
correlation with CRP. PLR showed a positive correla-
tion with fever, CRP, neutrophil count and NLR, which 
are indicators of inflammation. Details of the corre-
lation analysis are shown in Table 2. Scatter Plots of 
laboratory parameters are shown in Figure 1.
DISCUSSION
It was shown in previous studies that although the 
first clinical symptom in detecting cases was pneumo-
nia in COVID-19, it was also shown that it can also 
proceed with gastrointestinal symptoms or asympto-
matically [10]. COVID-19 needs to be continuously 
improved and accelerated in terms of clinical diagno-
sis and treatment to control the spread, considering 
its spread and serious systemic effects [10, 11].
CCT is one of the most important means of di-
agnosis in many lung diseases, including pneumonia 
[12]. It was reported that the COVID-19 Report-
ing and Data System (CO-RADS) Classification for 
COVID-19 pneumonia is a categorical evaluation 
scheme for pulmonary involvement in unenhanced 
CCT, which has a predictive value in COVID-19 in pa-
tients with moderate and severe symptoms [9, 13]. 
In our study, a total of 42 patients who described 
dyspnea complaints underwent CCT, and 13 patients 
(30.9%) were reported to have findings associated 
with pneumonia.
In a study, it which COVID-19 positive 75 pa-
tients were evaluated, 60% of the patients were 
identified as male. In our study, male gender was 
found to be dominant in COVID-19 positive group, 
which is in line with the literature [14].
It was reported previously that the presence of 
comorbidity and smoking deteriorated the progno-
sis of COVID-19 patients [17]. In our study, 45.9% of 
patients had no comorbidities, and 29.3% of them 
were active smokers. However, no differences were 
detected between COVID-19 positive and negative 
groups in terms of smoking and comorbidity.
The most common complaints detected in 
COVID-19 patients were determined as fever, cough 
and sore throat [14]. In our study; however, the 
most common admission complaints were cough, 
fever and shortness of breath, respectively.
Huang et al. [16] referred to SaO2 as another indi-
cator of the disease progression. It was reported previ-
ously that SaO2 was in close relation with hospitaliza-
tion and mortality, and the cut-off value for SaO2 was 
93% in determining COVID-19 seriousness. In our 
study, SaO2 value was 94.06% in the COVID-19 
positive group, and 95.9% in the COVID-19 neg-
ative group, and this difference was found to be 
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significant (p = 0.027). We believe that the low 
SaO2 levels in our patient group were because of the 
damage the virus did directly on the lungs. 
Yang et al. [17] classified COVID-19 patients as 
severe/non-severe. WBC was found to be higher at 
significant levels in the severe group, and a signifi-
cant correlation was detected between NLR eleva-
tion and COVID-19 risk. Terpos et al. [18] reported 
that the WBC count was normal or slightly lower in 
the early stages of the disease. Similarly, in a study 
investigating laboratory parameters in the diagnosis 
of COVID-19 in the first 2 months of the outbreak, 
WBC was detected to be decreased in 33.7% of pa-
tients [3]. In our study, on the other hand, the WBC 
count was found to be low in the COVID-19 pos-
itive group. This decrease can be associated with 
the decrease in neutrophil and lymphocyte param-
eters, but according to the data we obtained, we 
believe that it does not provide adequate data in 
COVID-19 suspicion. 
It was shown in different studies that COVID-19 
positive patients had decreased lymphocyte count, 
Table 1. Demographic, clinical, laboratory and radiologic results of the study group
Parameters Total (n = 61) COVID-19+ (n = 32) COVID-19- (n = 29) p
Demographics








Comorbidity n (%) 33 (54.1) 16 (50) 17 (56.6) 0.5
Smoking (+)
n (%)
24 (39.3) 11 (34.4) 13 (44.8) 0.44
Clinical Parameters
SaO2 (%) 94.84 ± 7.4 94.06 ± 8.2 95.9 ± 6.3 0.027
Fever (C0) 36.79 ± 0.64 36.9 ± 0.64 36.6 ± 0.62 0.143
Laboratory Parameters
WBC (103/µL) 8.06 ± 4.27 6.90 ± 4.72 9.34 ± 3.36 0.001
Neutrophil (103/µL) 5.52 ± 3.9 5.01 ± 4.37 6.08 ± 3.37 0.017
Lymphocyte (103/µL) 2.06 ± 1.1 1.79 ± 0.96 2.37 ± 1.18 0.021
NLR 4.67 ± 7.3 5.23 ± 8.86 4.06 ± 5.21 0.977
CRP (mg/L) 26.93 ± 55.1 29.09 ± 56.29 24.55 ± 54.77 0.322
D-DIMER  µg/L 326.77 ± 575.6 304.40 ± 299.93 351.44 ± 780.56 0.056
FERRITIN µg/L 213.75 ± 378 278.96 ± 481.75 141.79 ± 197.81 0.549
LDH U/L 205.49 ± 137 219.28 ± 178.84 190.27 ± 68.61 0.301
PLT 103/µL 257.50 ± 68.9 250.93 ± 71.10 265.03 ± 68.05 0.52
MPV fL 7.58 ± 1.34 7.36 ± 1.07 7.83 ± 1.58 0.37
PCT (%) 0.19 ± 0.04 0.18 ± 0.04 0.20 ± 0.04 0.03
PDW (10(GSD)) 20.29 ± 1.14 20.23 ± 0.95 20.35 ± 1.34 0.913




























LDH — lactate dehydrogenase PLT; MPV — Mean Platelet Volume; NLR — Neutrophil/Lymphocyte Ratio CRP; PCT — plateletcrit; PDW — Platelet Distribution Width; PLR — Plate-
let-Lymphocyte Ratio; SaO2 — oxygen saturation; WBC — White Blood Cell
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which was associated with the prognosis [14, 17]. 
It was determined that this was because of the lithic 
effect of SARS-COV-2 in the cells and the atrophy 
effect of cytokine activation on lymphoid organs 
after SARS-COV-2 binds to angiotensin-converting 
enzyme 2 (ACE2) receptors expressed on the lym-
phocyte surface, which altogether caused a decrease 
in the lymphocyte turnover rate [19, 20]. In our 
study, the lymphocyte count was measured to be 
significantly low in the COVID-19 positive group 
(p = 0.021).
Neutrophil count was found to be elevated in 
severe COVID-19 group in various studies [14, 17]. 
In a prospective study that included 416 patients, 
19.7% of the patients had myocardial damage, 
and these patients had a higher number of neutro-
phils than others [21]. It was considered that these 
results were associated with the septic condition 
and advanced organ damage [17, 21]. Contrary to 
these data, the number of neutrophils was found to 
be lower in COVID-19 positive group in our study 
(p = 0.017). We believe that this is related to the 
fact that the patients included in our study were 
in good condition, and were patients in the early 
stages of the disease. 
It was reported that the NLR level is high in se-
vere COVID-19 group, which was associated with 
in-hospital mortality [14, 15]. In our study; howev-
er, no differences were detected in terms of NLR in 
COVID-19 positive group compared to the negative 
group. The reason for the difference between pre-
vious studies might be methodological, or can be 
explained with the fact that no significant elevation 
was detected in neutrophil count in our study.
In a previous study examining the relations be-
tween PLT parameters and mortality, it was deter-
mined that thrombocytopenia and low PCT were 
associated with an increase in in-hospital mortality; 
however, increases were detected in the PLT values in 
surviving patients during the disease, and low PCT was 
identified as an independent risk factor for mortality 
[22]. In our study, although the PLT count and MPV 
values were below the reference values in COVID-19 
positive group, no significant differences were de-
tected in this regard. It was found that the PCT value 
was lower in the COVID-19 positive group, which, 
as a finding, also has the potential to show that the 
COVID-19 positive patient group had a higher risk 
than the COVID-19 negative group (p = 0.03). 
PLR is a new index that shows inflammation. 
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the potential inflammatory indicator for clinical di-
agnosis of community-based pneumonia [23]. Qu 
et al. [23] showed the relation of low lymphocyte 
levels in admission with prognosis. Also, low PLT 
levels were associated with more serious diseases, 
and elevated PLR showed the degree of cytokine 
storm in monitoring COVID-19 patients. In our 
study, PLR value was higher in COVID-19 positive 
patients (p = 0.021); and in the correlation analysis, 
it was shown that PLR had a positive correlation 
with inflammation indicators, fever, CRP, neutrophil 
count and NLR. The significantly high PLR levels in 
COVID-19 positive patient group in our study may 
provide the clinician with an idea on early diagno-
sis. According to the results of our study, we believe 
that PLR might have an important value in COV-
ID-19 suspected patients in terms of the severity of 
inflammation, it may be supportive in the decision 
for tomography in patients admitted to emergency 
department with suspicion of COVID-19, and may 
be an important indicator in the hospitalization de-
cision of COVID-19 positive patients.
It was determined in our study that the lympho-
cyte count, neutrophil count, WBC and PCT were 
low in COVID-19 positive patients; and PLR and CO-
RADS were determined to be high. These parame-
ters were associated with disease severity in previous 
studies. Depending on the density in the laboratory 
work, the hemogram result can be obtained in ap-
proximately 5 minutes, and RT-PCR result must be 
expected after at least 1–3 hours. Rapid identifi-
cation and isolation of people suspected of SARS-
CoV-2 infection are essential [24]. In this context, 
we believe that these parameters, especially the PLR 
elevation, which supports the presence of inflamma-
tion, will provide important clues to the clinician for 
hospitalization, timely treatment and early isolation 
of patients admitted to the emergency department 
with non-specific symptoms and findings.
CONCLUSION
The SaO2, WBC, lymphocyte count, neutrophil 
count and low PCT levels, and PLR elevation showed 
a significant difference in COVID-19 patients in our 
retrospective cohort study examining the Turkish 
population. We believe that these results will allow 
clinicians to make quick decisions in patient man-
agement more simply; however, more studies are 
needed with wider patient populations.
fIgURE 1. Scatter plots of laboratory parameters
Burak Katipoğlu et al., Laboratory parameters and COVID-19
181www.journals.viamedica.pl
Ethics: Consent according to Helsinki declaration 
was taken from Ufuk University Faculty of Medicine 
ethics committee before the study  
(No: 20200521/9).
Statement of: The authors declared no potential 
conflicts of interest with respect to the research, 
authorship, and/or publication of this article.
Source of funding: None.
RefeRences
1. Ge H, Wang X, Yuan X, et al. The epidemiology and clinical infor-
mation about COVID-19. Eur J Clin Microbiol Infect Dis. 2020; 39(6): 
1011–1019, doi: 10.1007/s10096-020-03874-z, indexed in Pubmed: 
32291542.
2. Wang W, Tang J, Wei F. Updated understanding of the outbreak of 
2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol. 
2020; 92(4): 441–447, doi: 10.1002/jmv.25689, indexed in Pubmed: 
31994742.
3. Guan WJ, Ni ZY, Hu Yu, et al. China Medical Treatment Expert Group 
for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 
in China. N Engl J Med. 2020; 382(18): 1708–1720, doi: 10.1056/
NEJMoa2002032, indexed in Pubmed: 32109013.
4. Çınar E. Türkdoğan Pratik Acil Tıp, Section 10: Pneumonia, 1st Ed. 
(İstanbul: EMA Medicine Publisher. ; 2020: pp.
5. Mehta P, McAuley DF, Brown M, et al. HLH Across Speciality Col-
laboration, UK. COVID-19: consider cytokine storm syndromes and 
immunosuppression. Lancet. 2020; 395(10229): 1033–1034, doi: 
10.1016/S0140-6736(20)30628-0, indexed in Pubmed: 32192578.
6. Bangash MN, Patel J, Parekh D. COVID-19 and the liver: little cause 
for concern. Lancet Gastroenterol Hepatol. 2020; 5(6): 529–530, doi: 
10.1016/S2468-1253(20)30084-4, indexed in Pubmed: 32203680.
7. Kermali M, Khalsa RK, Pillai K, et al. The role of biomarkers in diagnosis 
of COVID-19 - A systematic review. Life Sci. 2020; 254: 117788, doi: 
10.1016/j.lfs.2020.117788, indexed in Pubmed: 32475810.
8. Turkish Health Ministry SARS Cov- 2 Infection Guide, English version 
avaible at: https://hsgm. saglik gov tr/depo/birimler/goc_sagligi/
covid19/rehber/COVID-19_Rehberi20200414_eng_v4_002_14 05. 
; 2020: pdf.
9. Prokop M, van Everdingen W, van Rees Vellinga T, et al. COVID-19 
Standardized Reporting Working Group of the Dutch Radiological 
Society. CO-RADS: A Categorical CT Assessment Scheme for Patients 
Suspected of Having COVID-19-Definition and Evaluation. Radiology. 
2020; 296(2): E97–E9E104, doi: 10.1148/radiol.2020201473, indexed 
in Pubmed: 32339082.
10. Chan JFW, Yuan S, Kok KH, et al. A familial cluster of pneumonia associ-
ated with the 2019 novel coronavirus indicating person-to-person trans-
mission: a study of a family cluster. Lancet. 2020; 395(10223): 514–523, 
doi: 10.1016/S0140-6736(20)30154-9, indexed in Pubmed: 31986261.
11. Zhao S, Lin Q, Ran J, et al. Preliminary estimation of the basic repro-
duction number of novel coronavirus (2019-nCoV) in China, from 2019 
to 2020: A data-driven analysis in the early phase of the outbreak. 
Int J Infect Dis. 2020; 92: 214–217, doi: 10.1016/j.ijid.2020.01.050, 
indexed in Pubmed: 32007643.
12. Bronchogenic cyst. Definitions. 2020, doi: 10.32388/3nvus9.
13. Radiological Society of North America Expert Consensus Statement 
on Reporting Chest CT Findings Related to COVID-19. Endorsed by 
the Society of Thoracic Radiology, the American College of Radiology, 
and RSNA. Radiology: Cardiothoracic Imaging. 2020, doi: 10.1148/
ryct.2020200152.podcast.
14. Fu J, Kong J, Wang W, et al. The clinical implication of dynamic neu-
trophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective 
study in Suzhou China. Thromb Res. 2020; 192: 3–8, doi: 10.1016/j.
thromres.2020.05.006, indexed in Pubmed: 32407937.
15. Liu Y, Du X, Chen J, et al. Neutrophil-to-lymphocyte ratio as an inde-
pendent risk factor for mortality in hospitalized patients with COV-
ID-19. J Infect. 2020; 81(1): e6–ee12, doi: 10.1016/j.jinf.2020.04.002, 
indexed in Pubmed: 32283162.
16. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 
novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497–506, 
doi: 10.1016/S0140-6736(20)30183-5, indexed in Pubmed: 31986264.
17. Yang AP, Liu JP, Tao WQ, et al. The diagnostic and predictive role of 
NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 
2020; 84: 106504, doi: 10.1016/j.intimp.2020.106504, indexed in 
Pubmed: 32304994.
18. Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological 
findings and complications of COVID-19. Am J Hematol. 2020; 95(7): 
834–847, doi: 10.1002/ajh.25829, indexed in Pubmed: 32282949.
19. Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of 2019-
nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020; 12(1): 
8, doi: 10.1038/s41368-020-0074-x, indexed in Pubmed: 32094336.
20. Chan JW, Zhang A, Yuan S, et al. Simulation of the Clinical and Patholog-
ical Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden 
Syrian Hamster Model: Implications for Disease Pathogenesis and Trans-
missibility. Clinical Infectious Diseases. 2020, doi: 10.1093/cid/ciaa325.
21. Shi S, Qin Mu, Shen Bo, et al. Association of Cardiac Injury With Mor-
tality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA 
Cardiol. 2020; 5(7): 802–810, doi: 10.1001/jamacardio.2020.0950, 
indexed in Pubmed: 32211816.
22. Liu Y, Sun W, Guo Y, et al. Association between platelet parameters and 
mortality in coronavirus disease 2019: Retrospective cohort study. Plate-
lets. 2020; 31(4): 490–496, doi: 10.1080/09537104.2020.1754383, 
indexed in Pubmed: 32297540.
23. Qu R, Ling Y, Zhang YH, et al. Platelet-to-lymphocyte ratio is associated with 
prognosis in patients with coronavirus disease-19. J Med Virol. 2020 [Epub 
ahead of print], doi: 10.1002/jmv.25767, indexed in Pubmed: 32181903.
24. Smereka J, Szarpak L, Filipiak K. Modern medicine in COVID-19 era. 
Disaster and Emergency Medicine Journal. 2020, doi: 10.5603/demj.
a2020.0012.
